Samuel Broder et al., “A Pathogenic Retrovirus (HTLV-III) Linked to AIDS”, The New England Journal of Medicine, Nov. 15, 1984, pp. 1292-1297. |
Luc Montagnier et al., “Lymphadenopathy Associated Virus and AIDS”, Clinical Immunology Newsletter, vol. 6, No. 5, May 1985, pp. 65-68. |
Burgard, et al., AIDS 3:665-668 (1989). |
Kaplan, et al., Am. J. Med. 82:615-620 (1987). |
Cheson, et al., J. Am. Med. Assoc. 258:1347-1351 (1987). |
Eeftinck-Schattenkerk, et al., Arch. Intern. Med. 148:209-211 (1988). |
Jacobson, et al., J. Infect. Dis. 158:862-865 (1988). |
Reddy, et al., J. Infect. Dis. 166:607-610 (1992). |
Fletcher, et al., Antimicrobial Agents and Chemotherapy 38:604-607 (1994). |
Palestine, et al., Annuals Intern. Med. 115:665-673 (1991). |
Kaiser, et al., Poster PB0842, 10th International Conference on AIDS, Yokohama (1994). |
“Soon A Drug Against AIDS Will be Available”, Arbetet, Nov. 2, 1984. |
John S. Oxford et al., Conquest of Viral Diseases, Elsevier Science Publishers B.V. May 1, 1985, p. 591. |
Eric G. Sandstrom et al., “Inhibition of Human T-Cell Lymphotropic Virus Type III In Vitro by Phosphonoformate”, The Lancet, Jun. 29, 1985, pp. 1480-1482. |